OPKO Health, Inc. Construction in Progress, Gross
OPKO Health, Inc. (OPK) had Construction in Progress, Gross of $16.67 million as of 2018-12-31, per its 10-K filed 2019-03-01.
Discontinued › Balance Sheet › Assets › Assets, Noncurrent › Property, Plant, and Equipment, before Accumulated Depreciation, Depletion, and Amortization
us-gaap:ConstructionInProgressGross · last filed 2019-03-01
- 2018-12-31: Construction in Progress, Gross $16.67M.
- 2017-12-31: Construction in Progress, Gross $39.40M.
- 2016-12-31: Construction in Progress, Gross $5.85M.
- 2015-12-31: Construction in Progress, Gross $425.00K.
| Period end | Construction in Progress, Gross |
|---|---|
| 2018-12-31 | $16.67M 10-K · filed 2019-03-01 |
| 2017-12-31 | $39.40M 10-K · filed 2019-03-01 |
| 2016-12-31 | $5.85M 8-K · filed 2019-01-29 |
| 2015-12-31 | $425.00K 10-K · filed 2017-03-01 |
| 2014-12-31 | $225.00K 10-K · filed 2016-02-29 |
| 2013-12-31 | $489.00K 10-K · filed 2015-02-27 |
| 2012-12-31 | $0.00 10-K · filed 2014-03-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| LB PHARMACEUTICALS INC (LBRX) | United States | $1.220B | -10.87 |
| HARROW, INC. (HROW) | United States | $1.240B | -42.77 |
| Damora Therapeutics, Inc. (DMRA) | $1.250B | -6.10 | |
| Jaguar Health, Inc. (JAGX) | United States | $1.184B | |
| Latigo Biotherapeutics, Inc. (LTGO) | United States | $1.176B | |
| Avalyn Pharma Inc. (AVLN) | United States | $1.267B | |
| First Tracks Biotherapeutics, Inc. (TRAX) | United States | $1.280B | |
| Bicara Therapeutics Inc. (BCAX) | United States | $1.309B | -10.55 |
| Seaport Therapeutics, Inc. (SPTX) | United States | $1.131B | |
| Amphastar Pharmaceuticals, Inc. (AMPH) | United States | $1.116B | 10.93 |